Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors

Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses

(2014) M. Y. Gerner et al.   JOURNAL OF IMMUNOLOGY

Natural Innate and Adaptive Immunity to Cancer

(2011) Matthew D. Vesely et al.   Annual Review of Immunology

Th17 differentiation is the default program for DPP2-deficient T-cell differentiation

(2011) Deanna A. Mele et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

(2011) David L. Porter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy

(2011) Joanna L. Meadors et al.   PEDIATRIC BLOOD & CANCER

Incretin-Based Therapies: Review of Current Clinical Trial Data

(2010) Anne Peters   AMERICAN JOURNAL OF MEDICINE

Pediatric Phase I Trial Design Using Maximum Target Inhibition as the Primary Endpoint

(2010) Holly Meany et al.   JNCI-Journal of the National Cancer Institute

Lipid accumulation and dendritic cell dysfunction in cancer

(2010) Donna L Herber et al.   NATURE MEDICINE

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein- 

(2010) M. Kraman et al.   SCIENCE

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

(2009) Robert M Eager et al.   BMC CANCER

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease

(2009) Angela Pennisi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches

(2009) Terry J. Fry et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer

(2009) R.M. Eager et al.   CLINICAL ONCOLOGY

In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb

(2009) Oihana Murillo et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

(2009) Angélica M. Santos et al.   JOURNAL OF CLINICAL INVESTIGATION

Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells

(2009) M. Y. Gerner et al.   JOURNAL OF IMMUNOLOGY

Enhancing the efficacy of cancer vaccines in urologic oncology: new directions

(2009) Sergei Kusmartsev et al.   Nature Reviews Urology

HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat

(2008) Anthony D. Cristillo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Phenotypic and Functional Analysis of Dendritic Cells and Clinical Outcome in Patients With High-Risk Melanoma Treated With Adjuvant Granulocyte Macrophage Colony-Stimulating Factor

(2008) Adil I. Daud et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Immunotherapy

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

(2008) K. Hildner et al.   SCIENCE